Multaq 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM5D0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,028
Award facts
- Contract value 100% obligated
- $6,028.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,028.44 to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count packages) on November 28, 2025, with a completion date of December 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. The SPE2DX indefinite delivery vehicle functions as a comprehensive global pharmaceutical support contract, enabling the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. MULTAQ (dronedarone) is an antiarrhythmic medication used in cardiac care, reflecting the company's extensive portfolio of specialty and brand-name pharmaceutical products delivered through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26FM5D0?
SPE2DR26FM5D0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26FM5D0 worth?
The government has obligated $6,028 on SPE2DR26FM5D0.
Is contract SPE2DR26FM5D0 an order under another contract?
Yes. SPE2DR26FM5D0 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM5D0 competed?
The extent of competition for SPE2DR26FM5D0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award